Efficacy of combined therapy with paclitaxel and low-level ultrasound in human chronic myelogenous leukemia cell line K562

References

• De Boer RH, Kotasek D, White S, et al. Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer. Breast Cancer Res Treat 2012;135:241–52
   PubMed Web of Science ®Google Scholar
• Dizon DS, Damstrup L, Finkler NJ, et al. Phase II activity of belinostat (PXD-101), carboplatin, and paclitaxel in women with previously treated ovarian cancer. Int J Gynecol Cancer 2012;22:979–86
   PubMed Web of Science ®Google Scholar
• Lynch TJ, Bondarenko I, Luft A, et al. Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study. J Clin Oncol 2012;30:2046–54
   PubMed Web of Science ®Google Scholar
• Fleming DR, Glisson SD, Bhupalam L, et al. Phase I study of paclitaxel and day 1/day 8 gemcitabine in patients with solid malignancies. Am J Clin Oncol 2000;23:349–52
   PubMed Web of Science ®Google Scholar
• Tseng CJ, Wang YJ, Liang YC, et al. Microtubule damaging agents induce apoptosis in HL 60 cells and G2/M cell cycle arrest in HT 29 cells. Toxicology 2002;175:123–42
   PubMed Web of Science ®Google Scholar
• Koudelka S, Turánek J. Liposomal paclitaxel formulations. J Control Release 2012;163:322–34
   PubMed Web of Science ®Google Scholar
• Gelderblom H, Verweij J, Nooter K, et al. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer 2001;37:1590–8
   PubMed Web of Science ®Google Scholar
• Rowinsky EK, Donehower RC. Paclitaxel (taxol). N Engl J Med 1995;332:1004–14
   PubMed Web of Science ®Google Scholar
• Weiss RB, Donehower RC, Wiernik PH, et al. Hypersensitivity reactions from taxol. J Clin Oncol 1990;8:1263–8
   PubMed Web of Science ®Google Scholar
• Luo C, Wang Y, Chen Q, et al. Advances of paclitaxel formulations based on nanosystem delivery technology. Mini Rev Med Chem 2012;12:434–44
   PubMed Web of Science ®Google Scholar
• Ando M, Yonemori K, Katsumata N, et al. Phase I and pharmacokinetic study of nab-paclitaxel, nanoparticle albumin-bound paclitaxel, administered weekly to Japanese patients with solid tumors and metastatic breast cancer. Cancer Chemother Pharmacol 2012;69:457–65
   PubMed Web of Science ®Google Scholar
• Elsadek B, Kratz F. Impact of albumin on drug delivery – new applications on the horizon. J Control Release 2012;157:4–28
   PubMed Web of Science ®Google Scholar
• Cho JY, Kim SH, Kim SY, et al. Efficacy and safety of daily repeated sonographically guided high-intensity focused ultrasound treatment of uterine fibroids: preliminary study. J Ultrasound Med 2013;32:397–406
   PubMed Web of Science ®Google Scholar
• Kennedy JE, Ter Haar GR, Cranston D. High intensity focused ultrasound: surgery of the future? Br J Radiol 2003;76:590–9
   PubMed Web of Science ®Google Scholar
• Wang K, Zhu H, Meng Z, et al. Safety evaluation of high-intensity focused ultrasound in patients with pancreatic cancer. Onkologie 2013;36:88–92
   PubMed Web of Science ®Google Scholar
• Barati AH, Mokhtari-Dizaji M, Mozdarani H, et al. Effect of exposure parameters on cavitation induced by low-level dual-frequency ultrasound. Ultrason Sonochem 2007;14:783–9
   PubMed Web of Science ®Google Scholar
• Rosenthal I, Sostaric JZ, Riesz P. Sonodynamic therapy – a review of the synergistic effects of drug and ultrasound. Ultrason Sonochem 2004;11:349–63
   PubMed Web of Science ®Google Scholar
• Shanei A, Sazgarnia A, Tayyebi Meibodi N, et al. Sonodynamic therapy using protoporphyrin IX conjugated to gold nanoparticles: an in vivo study on a colon tumor model. Iran J Basic Med Sci 2012;15:759–67
   PubMed Web of Science ®Google Scholar
• Wang P, Li Y, Wang X, et al. Membrane damage effect of continuous wave ultrasound on K562 human leukemia cells. J Ultrasound Med 2012;31:1977–86
   PubMed Web of Science ®Google Scholar
• Wang P, Wang X, Zhang K, et al. The spectroscopy analyses of PpIX by ultrasound irradiation and its sonotoxicity in vitro. Ultrasonics 2013;53:935–42
   PubMed Web of Science ®Google Scholar
• Wang X, Wang P, Zhang K, et al. Initiation of autophagy and apoptosis by sonodynamic therapy in murine leukemia L1210 cells. Toxicol In Vitro 2012;27:1247–59
   PubMed Web of Science ®Google Scholar
• Yu T, Wang Z, Mason TJ. A review of research into the uses of low level ultrasound in cancer therapy. Ultrason Sonochem 2004;11:95–103
   PubMed Web of Science ®Google Scholar
• He H, Yu T, Zhang Y. The interaction between a drug and ultrasound in sonochemotherapy against ovarian cancers. Ultraschall Med 2012;33:275–82
   PubMed Web of Science ®Google Scholar
• Jin ZJ. About the evaluation of drug combination. Acta Pharmacol Sin 2004;25:146–7
   PubMed Web of Science ®Google Scholar
• Hao Q, Liu Q, Wang X, et al. Membrane damage effect of therapeutic ultrasound on Ehrlich ascitic tumor cells. Cancer Biother Radiopharm 2009;24:41–8
   PubMed Web of Science ®Google Scholar
• Verma M, Singh SK, Bhushan S, et al. In vitro cytotoxic potential of polyalthia longifolia on human cancer cell lines and induction of apoptosis through mitochondrial-dependent pathway in HL60 cells. Chem Biol Interact 2008;171:45–56
   PubMed Web of Science ®Google Scholar
• Yu T, Wang Z, Jiang S. Potentiation of cytotoxicity of adriamycin on human ovarian carcinoma cell line 3AO by low-level ultrasound. Ultrasonics 2001;39:307–9
   PubMed Web of Science ®Google Scholar
• Tachibana K, Uchida T, Tamura K, et al. Enhanced cytotoxic effect of Ara-C by low intensity ultrasound to HL-60 cells. Cancer Lett 2000;149:189–94
   PubMed Web of Science ®Google Scholar
• Arthur C, Flaig T, Su LJ, et al. The effect of ultrasonic irradiation on doxorubicin-induced cytotoxicity in three human bladder cancer cell lines. Ultrasonics 2007;46:68–73
   PubMed Web of Science ®Google Scholar
• Yu T, Li SL, Zhao JZ, et al. Ultrasound: a chemotherapy sensitizer. Technol Cancer Res Treat 2006;5:51–60
   PubMed Web of Science ®Google Scholar
• Marin A, Muniruzzaman M, Rapoport N. Mechanism of the ultrasonic activation of micellar drug delivery. J Control Release 2001;75:69–81
   PubMed Web of Science ®Google Scholar
• Yu T, Zhang Y, He H, et al. Anticancer potency of cytotoxic drugs after exposure to high-intensity focused ultrasound in the presence of microbubbles and hematoporphyrin. Mol Pharm 2011;8:1408–15
   PubMed Web of Science ®Google Scholar
• Jackson JK, Pirmoradi FN, Wan CP, et al. Increased accumulation of paclitaxel and doxorubicin in proliferating capillary cells and prostate cancer cells following ultrasound exposure. Ultrasonics 2011;51:932–9
   PubMed Web of Science ®Google Scholar
• Miller DL, Pislaru SV, Greenleaf JE. Sonoporation: mechanical DNA delivery by ultrasonic cavitation. Somat Cell Mol Genet 2002;27:115–34
   PubMedGoogle Scholar
• Liang L, Xie S, Jiang L, et al. The combined effects of hematoporphyrin monomethyl ether-SDT and doxorubicin on the proliferation of QBC939 cell lines. Ultrasound Med Biol 2013;39:146–60
   PubMed Web of Science ®Google Scholar
• Sorace AG, Warram JM, Umphrey H, et al. Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer. J Drug Target 2012;20:43–54
   PubMed Web of Science ®Google Scholar
• Cosco D, Paolino D, Maiuolo J, et al. Liposomes as multicompartmental carriers for multidrug delivery in anticancer chemotherapy. Drug Deliv Transl Res 2011;1:66–75
   Web of Science ®Google Scholar
• Niu G, Castro CH, Nguyen N, et al. In vitro cytotoxic activity of cationic paclitaxel nanoparticles on MDR-3T3 cells. J Drug Target 2010;18:468–76
   PubMed Web of Science ®Google Scholar
• Eggen S, Afadzi M, Nilssen EA, et al. Ultrasound improves the uptake and distribution of liposomal doxorubicin in prostate cancer xenografts. Ultrasound Med Biol 2013;39:1255–66
   PubMed Web of Science ®Google Scholar
• Yan F, Li L, Deng Z, et al. Paclitaxel-liposome-microbubble complexes as ultrasound-triggered therapeutic drug delivery carriers. J Control Release 2013;166:246–55
   PubMed Web of Science ®Google Scholar
• Zhao L, Ye Y, Li J, et al. Preparation and the in-vivo evaluation of paclitaxel liposomes for lung targeting delivery in dogs. J Pharm Pharmacol 2011;63:80–6
   PubMed Web of Science ®Google Scholar
• Zhang Z, Mei L, Feng SS. Paclitaxel drug delivery systems. Expert Opin Drug Deliv 2013;10:325–40
   PubMed Web of Science ®Google Scholar